Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-d-tryptophan-luteinizing Hormone-releasing Factor (pig)
2. Ay 25650
3. Ay-25650
4. Ay25650
5. Cl 118532
6. Cl-118532
7. Cl118532
8. D-trp-6-lh-rh
9. Decapeptyl
10. Decapeptyl Depot
11. Decapeptyl Lp
12. Decapeptyl Trimestral
13. Embonate, Triptorelin
14. Gnrh, Trp(6)-
15. Lhrh, Trp(6)-
16. Lhrh, Tryptophyl(6)-
17. Pamoate, Triptorelin
18. Trelstar
19. Trimestral, Decapeptyl
20. Triptorelin
21. Triptorelin Embonate
22. Triptorelin Pamoate
23. Wy 42462
24. Wy-42462
25. Wy42462
1. 140194-24-7
2. 140194-24-7 (acetate)
3. Bim 21003
4. Wy 42422
5. Wy 42462
6. Ay 25650
7. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-gly-nh2 Acetate
8. Decapeptyl (tn)
9. (s)-n-(2-amino-2-oxoethyl)-1-(((s)-5-oxopyrrolidine-2-carbonyl)-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl)pyrrolidine-2-carboxamide Acetate
10. Unii-43ofw291r9
11. Bim 21003c
12. 43ofw291r9
13. Dtxsid301033427
14. 6-d-tryptophan Luteinizing Hormone-releasing Factor (swine) Acetate
15. Hy-12551a
16. Akos030485974
17. Cs-0012388
18. Propan-2-yl]-5-oxopyrrolidine-2-carboxamide
19. D08649
20. J-007369
21. Q27258659
22. Luteinizing Hormone-releasing Factor (swine), 6-d-tryptophan-, Acetate (1:1)
23. 2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1h-imidazol-4-yl)-1-oxo
24. Acetic Acid;(2s)-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[(2s)-1-[[(2s)-1-[(2s)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-
Molecular Weight | 1371.5 g/mol |
---|---|
Molecular Formula | C66H86N18O15 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 33 |
Exact Mass | 1370.65200411 g/mol |
Monoisotopic Mass | 1370.65200411 g/mol |
Topological Polar Surface Area | 528 Ų |
Heavy Atom Count | 99 |
Formal Charge | 0 |
Complexity | 2750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
Luteolytic Agents
Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)
QH01CA97
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Triptorelin Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Triptorelin Acetate, including repackagers and relabelers. The FDA regulates Triptorelin Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Triptorelin Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Triptorelin Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Triptorelin Acetate supplier is an individual or a company that provides Triptorelin Acetate active pharmaceutical ingredient (API) or Triptorelin Acetate finished formulations upon request. The Triptorelin Acetate suppliers may include Triptorelin Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Triptorelin Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Triptorelin Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Triptorelin Acetate active pharmaceutical ingredient (API) in detail. Different forms of Triptorelin Acetate DMFs exist exist since differing nations have different regulations, such as Triptorelin Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Triptorelin Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Triptorelin Acetate USDMF includes data on Triptorelin Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Triptorelin Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Triptorelin Acetate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Triptorelin Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Triptorelin Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Triptorelin Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Triptorelin Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Triptorelin Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Triptorelin Acetate suppliers with NDC on PharmaCompass.
Triptorelin Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Triptorelin Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Triptorelin Acetate GMP manufacturer or Triptorelin Acetate GMP API supplier for your needs.
A Triptorelin Acetate CoA (Certificate of Analysis) is a formal document that attests to Triptorelin Acetate's compliance with Triptorelin Acetate specifications and serves as a tool for batch-level quality control.
Triptorelin Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Triptorelin Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Triptorelin Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Triptorelin Acetate EP), Triptorelin Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Triptorelin Acetate USP).
LOOKING FOR A SUPPLIER?